415 related articles for article (PubMed ID: 22269411)
1. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
Salhab M; Canelo R
J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
[TBL] [Abstract][Full Text] [Related]
2. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
3. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
Lan T; Chang L; Mn R; Wu L; Yuan YF
Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
[TBL] [Abstract][Full Text] [Related]
4. Multimodal approaches to the treatment of hepatocellular carcinoma.
Cabibbo G; Latteri F; Antonucci M; Craxì A
Nat Clin Pract Gastroenterol Hepatol; 2009 Mar; 6(3):159-69. PubMed ID: 19190599
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
Hoffmann K; Glimm H; Radeleff B; Richter G; Heining C; Schenkel I; Zahlten-Hinguranage A; Schirrmacher P; Schmidt J; Büchler MW; Jaeger D; von Kalle C; Schemmer P
BMC Cancer; 2008 Nov; 8():349. PubMed ID: 19036146
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.
Zeng J; Lv L; Mei ZC
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):688-697. PubMed ID: 27339594
[TBL] [Abstract][Full Text] [Related]
12. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.
Orlando A; Leandro G; Olivo M; Andriulli A; Cottone M
Am J Gastroenterol; 2009 Feb; 104(2):514-24. PubMed ID: 19174803
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
Tiong L; Maddern GJ
Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
[TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis.
Xu RH; Gao W; Wang C; Guo DK; Tang L; Zhang H; Wang CJ
Eur J Med Res; 2014 Aug; 19(1):39. PubMed ID: 25141776
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
Dong W; Zhang T; Wang ZG; Liu H
World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
19. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.
Cho YK; Kim JK; Kim MY; Rhim H; Han JK
Hepatology; 2009 Feb; 49(2):453-9. PubMed ID: 19065676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
